NAYABEI BARRETTO: Open Payments
NPI 1407145477 · SANTA ROSA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$240 in 6 payments from 4 companies in 2025. Trend: 2023 $457 · 2024 $107 · 2025 $240
Food & beverage: $240
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $159 |
| Lilly USA, LLC | 1 | $31 |
| ABBVIE INC. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: Ozempic, MOUNJARO, UBRELVY, RECORLEV.
Industry payments across CA — which companies pay providers there.
